170 related articles for article (PubMed ID: 19958120)
1. Robo1: a potential role in ocular angiogenesis.
Huang L; Xu Y; Yu W; Li X; Liqun C; He X; Peiying H
Curr Eye Res; 2009 Dec; 34(12):1019-29. PubMed ID: 19958120
[TBL] [Abstract][Full Text] [Related]
2. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
3. Robo1/robo4: different expression patterns in retinal development.
Huang L; Yu W; Li X; Niu L; Li K; Li J
Exp Eye Res; 2009 Mar; 88(3):583-8. PubMed ID: 19084519
[TBL] [Abstract][Full Text] [Related]
4. Expression of Robo4 in the fibrovascular membranes from patients with proliferative diabetic retinopathy and its role in RF/6A and RPE cells.
Huang L; Yu W; Li X; Xu Y; Niu L; He X; Dong J; Yan Z
Mol Vis; 2009 May; 15():1057-69. PubMed ID: 19495426
[TBL] [Abstract][Full Text] [Related]
5. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
6. Suppression of ICAM-1 in retinal and choroidal endothelial cells by plasmid small-interfering RNAs in vivo.
Hirano Y; Sakurai E; Matsubara A; Ogura Y
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):508-15. PubMed ID: 19578010
[TBL] [Abstract][Full Text] [Related]
7. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
8. Functionally defining the endothelial transcriptome, from Robo4 to ECSCR.
Verissimo AR; Herbert JM; Heath VL; Legg JA; Sheldon H; Andre M; Swain RK; Bicknell R
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1214-7. PubMed ID: 19909249
[TBL] [Abstract][Full Text] [Related]
9. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of retinal neovascularization by soluble EphA2 receptor.
Chen J; Hicks D; Brantley-Sieders D; Cheng N; McCollum GW; Qi-Werdich X; Penn J
Exp Eye Res; 2006 Apr; 82(4):664-73. PubMed ID: 16359662
[TBL] [Abstract][Full Text] [Related]
11. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
12. Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model.
Akkoyun I; Yilmaz G; Oto S; Kahraman B; Haberal N; Akova YA
Acta Ophthalmol Scand; 2007 Nov; 85(7):791-4. PubMed ID: 17488319
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin-1 independent microvessel proliferation in a neonatal mouse model of oxygen-induced retinopathy.
Ruiz-Ederra J; Verkman AS
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4802-10. PubMed ID: 17898307
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).
Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
17. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
[TBL] [Abstract][Full Text] [Related]
18. Potential anti-angiogenic role of Slit2 in corneal neovascularization.
Han X; Zhang MC
Exp Eye Res; 2010 Jun; 90(6):742-9. PubMed ID: 20298689
[TBL] [Abstract][Full Text] [Related]
19. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
20. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina.
Stitt AW; Graham D; Gardiner TA
Mol Vis; 2004 Jun; 10():432-8. PubMed ID: 15235573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
